Skip to main content

Saratoga Research & Investment Management

Position in NVO — Novo Nordisk A S

CIK 1477872 SARATOGA, CA

Position in NVO

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$155,134,271
+$28,849,181 QoQ
Shares Held
3,236,009
-5.8% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
8.90%
of 13F equity value
Holder Rank
#24
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Saratoga Research & Investment Management holds $291,481,502 across 5 Drug Manufacturers - General names. NVO ranks #1 (53.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
This page
3,236,009 $155,134,271

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $155,134,271 3,236,009
2026-03-31 $126,285,090 3,436,329
2025-12-31 $94,258,558 1,852,566
2025-09-30 $102,862,201 1,853,707
2025-06-30 $104,404,966 1,512,677
2025-03-31 $100,976,870 1,454,160
2024-12-31 $60,268,536 700,634
2024-09-30 $84,363,357 708,519
2024-06-30 $106,871,864 748,717
2024-03-31 $100,638,764 783,791
2023-12-31 $85,614,599 827,594
2023-09-30 $80,951,605 890,165
2023-06-30 $74,068,296 457,692
2023-03-31 $74,696,178 469,374
2022-12-31 $91,806,129 678,337
2022-09-30 $69,632,303 698,909
2022-06-30 $78,769,421 706,896
2022-03-31 $87,318,170 786,296
2021-12-31 $89,426,848 798,454
2021-09-30 $80,185,439 835,178
2021-06-30 $103,699,804 1,237,911
2021-03-31 $82,415,826 1,222,424
2020-12-31 $81,563,635 1,167,697
2020-09-30 $79,360,017 1,143,022
2020-06-30 $77,726,593 1,187,028
2020-03-31 $91,549,150 1,520,750